April 3, 2023

---

España - FITONET, la red social de la biodiversidad vegetal, impulsada por Cellbitec

December 18, 2018

---

Calyxt receives EU patent on use of CRISPR/Cas9 for genome editing in plants

September 18, 2018

---

Calyx appoints James A. Bloome as Chief Executive Officer, effective October 1, 218

May 15, 2018

---

Calyxt announces launch of proposed follow-on offering

July 25, 2017

---

Calyxt announces full exercise of over-allotment option and closing of its initial public offering

July 10, 2017

---

Calyxt announces proposed initial public offering of $100.0 million

June 7, 2017

---

Calyxt names Joseph B. Saluri as General Counsel & EVP, Corporate Development

May 17, 2017

---

Calyxt launches U.S. field trials with University of Minnesota for powdery mildew-resistant spring wheat variety - Wheat marks Calyxt’s fourth gene edited crop to undergo trials

May 10, 2017

---

Calyxt patent encompassing broad uses of plant gene editing technologies maintained by USPTO - U.S. patent 8,921,332 refers to the use of chimeric endonucleases, such as zinc finger nucleases, TAL-effector nucleases, mega-TALs and CRISPR/Cas9 to precisely edit DNA within plant genomes

January 16, 2017

---

These foods aren’t genetically modified but they are ‘edited’ (The New York Times)

May 30, 2016

---

Calyxt appoints Federico A. Tripodi to new role of CEO

May 13, 2016

---

Cellectis reports first quarter 2016 financial results

October 15, 2015

---

Cellectis envisage d’introduire en Bourse sa filiale dédiée au développement de semences en propre, Calyx (Les Echos)

June 9, 2015

---

S&W Seed Company and Calyxt, Inc. announce alfalfa seed collaboration - Companies to apply next generation gene editing technology to the alfalfa seed industry 

April 16, 2015

---

Cellectis Plant Sciences, Inc. publishes a study demonstrating reduced acrylamide in fried potatoes

Cellectis Plant Sciences, Inc. locks early CRISPR intellectual property uses in plants - Cellectis plant sciences entered in an exclusive license agreement with the Regents of the University of Minnesota covering certain uses of CRISPR technology

December 18, 2014

---

Cellectis Plant Sciences and Two Blades Foundation announce the execution of a cross-license agreement on TAL Effector Nuclease technologies

July 3, 2014

---

Científicos franceses desarrollan soja con alto contenido oleico a través de mutagénesis dirigida

June 5, 2014

---

Cellectis et Thermo Fisher Scientific annoncent une série d’accords portant sur les TALEN, la technologie clé de l’ingénierie des génomes

May 27, 2014

---

Cellectis plant sciences reports generation of high oleic soybean in the Journal of Plant Biotechnology
Cellectis plant sciences annonce la production de soja à haute teneur en acide oléique dans le Journal of Plant Biotechnology

January 30, 2014

---

Precision BioSciences and Cellectis SA announce cross-license and settlement agreement for gene editing technology - Enables broad commercialization of highly specific engineered meganuclease technology

Bayer CropScience and Cellectis plant sciences extend their partnership to improve crops by gene editing
Bayer CropScience und Cellectis Plant Sciences bauen Partnerschaft weiter aus

January 9, 2014

---

Cellectis plant sciences announce the finalization of the first glycosylation lines of its program

December 5, 2013

---

Cellectis announces an acceleration of its strategic refocusing on therapeutics and agrobusiness

June 7, 2013

---

Cellectis plant sciences CEO Luc Mathis joins Board of Directors of the French Association for Plant Biotechnology (AFBV)

April 13, 2012

---

Cellectis affiche un potentiel de valorisation de plusieurs milliards (TradingSat)

January 31, 2012

---

Cellectis plant sciences announces the signature of a strategic partnership with SESVanderHave in sugar beet

January 3, 2012

---

Cellectis plant sciences and Bayer CropScience strengthen genome engineering partnership

April 8, 2011

---

Cellectis licenses novel biotech method co-developed at Iowa State University and University of Minnesota

February 28, 2011

---

Cellectis bioresearch met l’ingénierie des génomes à la portée de tous les laboratoires
Cellectis bioresearch makes genome engineering affordable for all users